GLP-1 receptor agonists represent a breakthrough in metabolic medicine. These compounds mimic the incretin hormone GLP-1, which regulates appetite, blood sugar, and insulin sensitivity.
How These Compounds Help
GLP-1 agonists work by slowing gastric emptying, increasing satiety signals to the brain, and improving insulin sensitivity. The result is reduced appetite, lower caloric intake, and improved metabolic markers including HbA1c, fasting glucose, and lipid profiles.
Who This Is For
This goal category is relevant for individuals seeking:
- Clinically significant weight loss (10%+ body weight)
- Improved metabolic health markers
- Appetite regulation support
- Body recomposition assistance